Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 removed, updating the page’s revision label to reflect a new version. This change is a metadata update rather than a modification to the study content or data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now includes new guidance and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays a recruitment status update ('No longer looking for participants'). The Intervention/Treatment header formatting was updated, and the revision label changed from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check53 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page content. This indicates an administrative update rather than changes to the study data or eligibility criteria.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a new page revision label: Revision: v3.5.4. Removed the previous Revision: v3.5.3 to reflect the latest version.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.